Skip to main content
All lobbying filings

NATIONAL MULTIPLE SCLEROSIS SOCIETY

Lobbying for NATIONAL MULTIPLE SCLEROSIS SOCIETY

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Expenses
$70,656.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 10
  • Centers For Disease Control & Prevention (CDC)
  • Centers For Medicare and Medicaid Services (CMS)
  • Defense, Dept of (DOD)
  • Food & Drug Administration (FDA)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • Natl Institutes of Health (NIH)
  • Office of Administration
  • SENATE
  • Veterans Affairs, Dept of (VA)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 15
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • S 752
    Accelerating Kids’ Access to Care Act
  • S 830
    Lifespan Respite Care Reauthorization Act of 2025
  • S 925
    Credit for Caring Act of 2025
  • S 976
    Insurance Fraud Accountability Act
  • HR 1509
    Accelerating Kids’ Access to Care Act of 2025
  • S 1816
    Improving Seniors’ Timely Access to Care Act of 2025
  • S 2024
    ENROLL Act of 2025
  • HR 2036
    Credit for Caring Act of 2025
  • HR 2079
    Insurance Fraud Accountability Act
  • HR 2320
    Mobility Means Freedom Tax Credit Act
  • HR 2560
    Lifespan Respite Care Reauthorization Act of 2025
  • HR 3417
    Websites and Software Applications Accessibility Act of 2025
  • HR 3514
    Improving Seniors’ Timely Access to Care Act of 2025
  • HR 3907
    ENROLL Act of 2025
 Lobbying activity 4
Budget/Appropriations

H.R.1 - One Big Beautiful Bill Act Supporting the following funding levels in FY25 appropriations bills: $51.3 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2026. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to restore funding for the Congressionally Directed MS Research Program which was zeroed out in the last Continuing Resolution. Specifically $22 million for the MS Research Program.

Health Issues

H.R. 1 - One Big Beautiful Bill Act S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025

Medicare/Medicaid

H.R.1 - One Big Beautiful Bill Act Joined with coalition partners to request CMS to expand coverage for anti-obesity medications. In June Commented and proposed recommendations on CMS's Draft Guidance for the Medicare Drug Price Negotiation Program.

Medical/Disease Research/Clinical Labs

H.R.1 - One Big Beautiful Bill Act Over the course of the last quarter joined with various coalition partners to advocate for restoring NIH funding grants for medical research.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem